Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengwen Liu

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Magnetic Resonance in Medicine|June 3, 2022
Multi-echo balanced SSFP with a sequential phase-encoding order for functional MR imaging at 7THuilou Liang, Ziyi Pan, Chencan Qian, et al.
Vaccine|October 13, 2010
Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccinesHong Qin, Soung-Chul Cha, Sattva S Neelapu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2010
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responsesWeiyi Peng, Yang Ye, Brian A Rabinovich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivoChengwen Liu, Carol M Lewis, Yanyan Lou, et al.
Cancer Immunology Research|October 5, 2016
IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell ActivationGeok Choo Sim, Chengwen Liu, Ena Wang, et al.
Science Signaling|September 29, 2016
Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cellsHaiyan S Li, Chengwen Liu, Yichuan Xiao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Antitumor activity mediated by CpG: the route of administration is criticalYanyan Lou, Chengwen Liu, Gregory Lizée, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2012
BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competencyDavid S Hong, Luis Vence, Gerald Falchook, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 30, 2016
Synthetic Poly(L-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy With Increased Retention in Tumor and Draining Lymph Nodes After Intratumoral Injection in a Mouse Model of MelanomaQing Ma, Dapeng Zhou, Elizabeth S DeLyria, et al.
Chemical Science|June 25, 2021
High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive samplingThéo Jaffrelot Inizan, Frédéric Célerse, Olivier Adjoua, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Magnetic Resonance in Medicine|June 3, 2022
Multi-echo balanced SSFP with a sequential phase-encoding order for functional MR imaging at 7THuilou Liang, Ziyi Pan, Chencan Qian, et al.
Vaccine|October 13, 2010
Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccinesHong Qin, Soung-Chul Cha, Sattva S Neelapu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2010
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responsesWeiyi Peng, Yang Ye, Brian A Rabinovich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivoChengwen Liu, Carol M Lewis, Yanyan Lou, et al.
Cancer Immunology Research|October 5, 2016
IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell ActivationGeok Choo Sim, Chengwen Liu, Ena Wang, et al.
Science Signaling|September 29, 2016
Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cellsHaiyan S Li, Chengwen Liu, Yichuan Xiao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Antitumor activity mediated by CpG: the route of administration is criticalYanyan Lou, Chengwen Liu, Gregory Lizée, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2012
BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competencyDavid S Hong, Luis Vence, Gerald Falchook, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 30, 2016
Synthetic Poly(L-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy With Increased Retention in Tumor and Draining Lymph Nodes After Intratumoral Injection in a Mouse Model of MelanomaQing Ma, Dapeng Zhou, Elizabeth S DeLyria, et al.
Chemical Science|June 25, 2021
High-resolution mining of the SARS-CoV-2 main protease conformational space: supercomputer-driven unsupervised adaptive samplingThéo Jaffrelot Inizan, Frédéric Célerse, Olivier Adjoua, et al.
Pageof 8